openPR Logo
Press release

Phosphoglucomutase (PGM 1) Deficiency Market Scope and Competitive Analysis Forecast through 2024-2031 - Avalo Therapeutics, Inc., Biosynth, BioSpectra, Inc.

11-18-2024 02:58 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Phosphoglucomutase (PGM 1) Deficiency Market

Phosphoglucomutase (PGM 1) Deficiency Market

The Phosphoglucomutase (PGM 1) Deficiency Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/phosphoglucomutase-deficiency-market

What is the projected growth rate (CAGR) of the Global Phosphoglucomutase (PGM 1) Deficiency market from 2024 to 2031, and what is the market value expected to change by 2031?

The Phosphoglucomutase (PGM 1) Deficiency Market is valued at a significant CAGR during the forecast period (2024-2031).

Phosphoglucomutase 1 (PGM 1) deficiency is a rare metabolic disorder that disrupts glucose metabolism, leading to glycogen storage and utilization issues. Symptoms include muscle weakness, hypoglycemia, and growth delays. It is classified under congenital disorders of glycosylation due to its impact on protein glycosylation. Diagnosis involves genetic testing and enzyme activity assays. Treatment focuses on managing symptoms, including dietary modifications and supplements like galactose. Early diagnosis is crucial to improving clinical outcomes and patient quality of life.

Key Developments:

❁ In July 2023, researchers explored the cardiac dysfunction associated with PGM1-CDG (Phosphoglucomutase 1 Congenital Disorder of Glycosylation) using a conditional Pgm2 knockout (KO) animal model Pgm2 being the mouse equivalent of human PGM1). Echocardiographic studies indicated a dilated cardiomyopathy (DCM) phenotype, showing significantly reduced ejection fraction and left ventricular enlargement, mirroring the cardiac abnormalities seen in human PGM1-CDG cases. The investigation revealed decreased mitochondrial activity in the hearts of the mutant mice. Transcriptomic analysis of these hearts identified a gene expression pattern consistent with DCM, offering insights into the molecular mechanisms underlying this cardiac dysfunction.

List of the Key Players in the Phosphoglucomutase (PGM 1) Deficiency Market:

Avalo Therapeutics, Inc., Biosynth, BioSpectra, Inc., Glentham Life Sciences Limited, ZellBio GmbH, Merck KGaA, Otto Chemie Pvt. Ltd., SRL Chemical, Fengchen Group Co.,Ltd and Pfanstiehl.

Research Process:

Both primary and secondary data sources have been used in the global Phosphoglucomutase (PGM 1) Deficiency Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Phosphoglucomutase (PGM 1) Deficiency Market:

By Involvement Type: Congenital Malformations, Neurological Involvement, Ophthalmologic Involvement, Endocrine Involvement, Cardiac Involvement, Gastrointestinal Involvement, Liver Involvement, Hematological/vascular Involvement, Muscular Involvement.

By Treatment: D-Galactose therapy, Gene Therapy.

By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics.

Regional Breakout:

The global Phosphoglucomutase (PGM 1) Deficiency Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

✫ North America (U.S., Canada, Mexico)

✫ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

✫ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

✫ South America (Colombia, Brazil, Argentina, Rest of South America)

✫ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Get Year End Discounts on Premium Report:- https://www.datamintelligence.com/buy-now-page?report=phosphoglucomutase-deficiency-market

This Report Unveils:

✔ Go to Market Strategy- A roadmap to successfully product launch or service in the target market.

✔ Gain a clear picture of the market's health and growth trajectory through neutral analysis.

✔ Deep Market Insights delve into development trends, competitor landscape, supply and demand dynamics, brand share & pricing analysis year-over-year growth patterns, and key players' performance.

✔ Upon request, we can provide customized reports focusing on specific regions or countries, offering a granular view of their markets.

✔ Identify high-potential niche segments and regions poised for significant expansion.

✔ Analysis of Market Size (historical and forecast) Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) to understand the market's overall size and your achievable market share.

✔ Gain a comprehensive understanding of the competitive landscape, including market share distribution, key players (innovators, startups, laggards, and pioneers), and their respective strengths and weaknesses.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Phosphoglucomutase (PGM 1) Deficiency manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Phosphoglucomutase (PGM 1) Deficiency in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the Phosphoglucomutase (PGM 1) Deficiency market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the Phosphoglucomutase (PGM 1) Deficiency market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/phosphoglucomutase-deficiency-market

Frequently Asked Questions

☞ What is the expected growth rate of the global Phosphoglucomutase (PGM 1) Deficiency market for the forecast period?

☞ What are the key driving factors that are responsible to shape the fate of the Phosphoglucomutase (PGM 1) Deficiency market during the forecast period?

☞ What will be the overall size of the market during the analysis period?

☞ What are the prominent market trends which influence the development of the Phosphoglucomutase (PGM 1) Deficiency market across various regions?

☞ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☞ What are the challenges and threats that are likely to act as a barrier to the growth of the Phosphoglucomutase (PGM 1) Deficiency market?

☞ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Phosphoglucomutase (PGM 1) Deficiency Market Scope and Competitive Analysis Forecast through 2024-2031 - Avalo Therapeutics, Inc., Biosynth, BioSpectra, Inc. here

News-ID: 3741601 • Views:

More Releases from DataM Intelligence 4market Research LLP

Non-Invasive Prenatal Testing (NIPT) Market Size to Hit USD 22.41 Bn by 2033 | 13.2% CAGR Growth | Major Companies are BGI, CENTOGENE AG, Eurofins Scientific
Non-Invasive Prenatal Testing (NIPT) Market Size to Hit USD 22.41 Bn by 2033 | 1 …
The global non-invasive prenatal testing (NIPT) market reached US$ 6.31 billion in 2023, with a rise of US$ 7.35 billion in 2024, and is expected to reach US$ 22.41 billion by 2033, growing at a CAGR of 13.2% during the forecast period 2025-2033. NIPT detects fetal genetic abnormalities using maternal blood, reducing the need for invasive procedures. Growth is driven by awareness, technological advancements, and increasing prenatal care adoption. Tests identify
Global qPCR Reagents Market Poised for Expansion Amid Rising Biotechnology Applications | Affymetrix Inc, Promega Corporation, Quanta Biosciences Inc
Global qPCR Reagents Market Poised for Expansion Amid Rising Biotechnology Appli …
qPCR Reagents Market is estimated to reach a high CAGR of 8.3% during the forecast period 2024-2031. qPCR Reagents are chemicals and kits used in quantitative polymerase chain reaction for gene expression, pathogen detection, and diagnostics. Growth is driven by molecular diagnostics, infectious disease monitoring, and biotechnology research. Reagents include primers, probes, enzymes, and buffers that enable high sensitivity and specificity. Key end-users include clinical labs, pharmaceutical companies, and academic research
Biopharmaceutical Tubing Market to Reach USD 6.67 Billion by 2031 | Driven by Single-Use Systems & Biologics Production | Top Companies are Rehu Group (RAUMEDIC AG), Genstar Capital (Tekni-Plex, Inc.), DuPont de Nemours, Inc.
Biopharmaceutical Tubing Market to Reach USD 6.67 Billion by 2031 | Driven by Si …
The Global Biopharmaceutical Tubing Market size reached USD 3,580.4 million in 2022 and is projected to witness lucrative growth by reaching up to USD 6,674.2 million by 2030. The biopharmaceutical tubing market is growing at a CAGR of 8.3% during the forecast period 2024-2031. Biopharmaceutical Tubing includes specialized tubes for transferring liquids and gases in drug manufacturing, cell culture, and bioprocessing. Growth is driven by increased biologics and vaccine production. Tubing
United States Clear Aligners Market Outlook 2031 | Trends, Growth Drivers, and Industry Analysis 2025 | Top Companies are Align Technology, Inc., Danaher, Institut Straumann AG
United States Clear Aligners Market Outlook 2031 | Trends, Growth Drivers, and I …
Clear Aligners Market is estimated to reach at a high CAGR 29.3% during the forecast period (2024-2031). Clear Aligners are orthodontic devices used to straighten teeth as an alternative to traditional braces. Growth is driven by aesthetic demand, technological advancements, and minimally invasive treatments. 3D scanning, CAD/CAM technology, and AI-driven treatment planning enhance precision. Dental clinics and orthodontic centers are primary end-users. Rising awareness of oral health and cosmetic dentistry supports

All 5 Releases


More Releases for PGM

PGM Recycling and Refining Market Growth: $631.5 Million by 2030 | Johnson Matth …
CALIFORNIA, (UNITED STATES) - The global PGM Recycling and Refining Market has witnessed significant growth and transformation in recent years. This comprehensive market report provides an overview of key trends, drivers, challenges, and opportunities in the industry. It covers various segments within the PGM Recycling and Refining sector, offering insights into market dynamics, competitive landscape, and future prospects. The report focuses on the major players that are in operation within
Phosphoglucomutase (PGM 1) Deficiency Market 2023-2030
Rising Research and Development Propels Phosphoglucomutase (PGM 1) Deficiency Market Growth: The global market for phosphoglucomutase (PGM 1) deficiency is witnessing a surge in research and development activities, driven by technological advancements and an increasing focus on understanding and treating this rare genetic condition. D-Galactose supplements are emerging as a key area of exploration for managing PGM 1 deficiency, showcasing a promising avenue for therapeutic interventions. The current trends in the phosphoglucomutase
Global Platinum Group Metals (PGM) Market (Platinum, Palladium & Rhodium) to Wit …
The global platinum group metals (PGM) supply is forecasted to reach 22.44 million ounces in 2024, growing at a CAGR of 6.8% for the period spanning 2020-2024. The factors such as accelerating industrialization, rapid urbanization, increasing fuel cell demand and high adoption of platinum-based medicines are expected to drive the market. However, growth of the industry would be challenged by stringent regulations. Few notable trends include growing demand of PGM
Trending 2020: PGM Catalysts Market || Booming Worldwide
Prophecy Market Insights recently presented PGM Catalysts market report which provides reliable and sincere insights related to the various segments and sub-segments of the market. The market study throws light on the various factors that are projected to impact the overall dynamics of the PGM Catalysts market over the forecast period (2019-2029). The PGM Catalysts research study contains 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and
Trending 2020: PGM || Catalysts Market Booming Worldwide
Prophecy Market Insights recently presented PGM Catalysts market report which provides reliable and sincere insights related to the various segments and sub-segments of the market. The market study throws light on the various factors that are projected to impact the overall dynamics of the PGM Catalysts market over the forecast period (2019-2029). The PGM Catalysts research study contains 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and
Phosphoglucomutase (PGM 1) Deficiency-Market Analysis, Opportunities and Detaile …
Market Research Hub (MRH) has actively discoursed a new study titled “Phosphoglucomutase (PGM 1) Deficiency-Market Insights, Epidemiology and Market” Forecast-2028, added to its vast online repository. The main motive of this assessment is to present clear insights about the growth factor experienced across the Phosphoglucomutase (PGM 1) Deficiency-Market during the forecast period. Readers can access vital information associated to prime market facets such as market size, market share, market drivers,